User profiles for Feng Ye
 | Ye FengSenior Manager, Biostatistics, Pfizer Verified email at usc.edu Cited by 1464 |
Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis
…, K Sun, W Pan, Z Zhan, L Chen, F Ye - Journal of medical …, 2020 - Wiley Online Library
The outbreak of the novel coronavirus disease (COVID‐19) quickly spread all over China
and to more than 20 other countries. Although the virus (severe acute respiratory syndrome …
and to more than 20 other countries. Although the virus (severe acute respiratory syndrome …
[HTML][HTML] Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
…, J Luo, C Ye, S Zhu, L Cheng, F Ye… - European …, 2020 - Eur Respiratory Soc
Background The coronavirus disease 2019 (COVID-19) outbreak is evolving rapidly worldwide.
Objective To evaluate the risk of serious adverse outcomes in patients with COVID-19 by …
Objective To evaluate the risk of serious adverse outcomes in patients with COVID-19 by …
Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients
…, D Liu, E Wang, X Xiao, S Li, F Ye… - European …, 2020 - Eur Respiratory Soc
In comparison to severe acute respiratory syndrome coronavirus (SARS-CoV), SARS-CoV-2
appears to be more contagious [1], and coronavirus disease 2019 (COVID-19) patients …
appears to be more contagious [1], and coronavirus disease 2019 (COVID-19) patients …
[HTML][HTML] Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions
…, Z Mai, J Liang, X Liu, S Li, Y Li, F Ye… - Journal of thoracic …, 2020 - ncbi.nlm.nih.gov
Background The coronavirus disease 2019 (COVID-19) outbreak originating in Wuhan,
Hubei province, China, coincided with chunyun, the period of mass migration for the annual …
Hubei province, China, coincided with chunyun, the period of mass migration for the annual …
[HTML][HTML] Kinetics of viral load and antibody response in relation to COVID-19 severity
Y Wang, L Zhang, L Sang, F Ye, S Ruan… - The Journal of …, 2020 - Am Soc Clin Investig
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent for
coronavirus 2019 (COVID-19) pneumonia. Little is known about the kinetics, tissue distribution…
coronavirus 2019 (COVID-19) pneumonia. Little is known about the kinetics, tissue distribution…
Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China
…, S Qiu, J Luo, C Ye, S Zhu, X Liu, L Cheng, F Ye… - Chest, 2020 - Elsevier
Background The novel coronavirus disease 2019 (COVID-19) has become a global health
emergency. The cumulative number of new confirmed cases and deaths are still increasing …
emergency. The cumulative number of new confirmed cases and deaths are still increasing …
Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors
Serum interleukin-8 (IL-8) levels and tumor neutrophil infiltration are associated with worse
prognosis in advanced cancers. Here, using a large-scale retrospective analysis, we show …
prognosis in advanced cancers. Here, using a large-scale retrospective analysis, we show …
HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the β-catenin–TCF interaction
F Ye, Y Chen, TN Hoang, RL Montgomery, X Zhao… - Nature …, 2009 - nature.com
Oligodendrocyte development is regulated by the interaction of repressors and activators in
a complex transcriptional network. We found that two histone-modifying enzymes, HDAC1 …
a complex transcriptional network. We found that two histone-modifying enzymes, HDAC1 …
[HTML][HTML] Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide …
…, J Luo, C Ye, S Zhu, L Cheng, F Ye… - European …, 2020 - Eur Respiratory Soc
Background During the outbreak of coronavirus disease 2019 (COVID-19), consistent and
considerable differences in disease severity and mortality rate of patients treated in Hubei …
considerable differences in disease severity and mortality rate of patients treated in Hubei …
Effect of camrelizumab vs placebo added to chemotherapy on survival and progression-free survival in patients with advanced or metastatic esophageal squamous …
…, S Gao, J Li, Z Fu, K Gu, Z Liu, L Wu, X Zhang, J Feng… - Jama, 2021 - jamanetwork.com
Importance Standard first-line therapy for advanced or metastatic esophageal carcinoma is
chemotherapy, but the prognosis remains poor. Camrelizumab (an anti–programmed death …
chemotherapy, but the prognosis remains poor. Camrelizumab (an anti–programmed death …